Quest Diagnostics (DGX) Total Current Liabilities: 2009-2025
Historic Total Current Liabilities for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to $2.1 billion.
- Quest Diagnostics' Total Current Liabilities rose 2.01% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 2.01%. This contributed to the annual value of $2.2 billion for FY2024, which is 19.50% up from last year.
- Latest data reveals that Quest Diagnostics reported Total Current Liabilities of $2.1 billion as of Q3 2025, which was up 5.43% from $2.0 billion recorded in Q2 2025.
- Quest Diagnostics' 5-year Total Current Liabilities high stood at $2.3 billion for Q1 2024, and its period low was $1.4 billion during Q1 2023.
- Its 3-year average for Total Current Liabilities is $1.9 billion, with a median of $2.0 billion in 2024.
- As far as peak fluctuations go, Quest Diagnostics' Total Current Liabilities soared by 69.59% in 2024, and later crashed by 37.29% in 2025.
- Over the past 5 years, Quest Diagnostics' Total Current Liabilities (Quarterly) stood at $1.8 billion in 2021, then dropped by 11.52% to $1.6 billion in 2022, then climbed by 17.02% to $1.8 billion in 2023, then rose by 19.50% to $2.2 billion in 2024, then increased by 2.01% to $2.1 billion in 2025.
- Its last three reported values are $2.1 billion in Q3 2025, $2.0 billion for Q2 2025, and $1.4 billion during Q1 2025.